Clinical Trial: Study to Assess the Safety and Patients' Satisfaction of Tears Again* in the Treatment of Dry Eye Symptoms

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open Study to Assess the Safety and Patients' Satisfaction Tears Again* in the Treatment of Dry Eye Symptoms

Brief Summary: The purpose of this study is to determine safety and patients' satisfaction when using Tears Again to treat Dry Eye Symptoms.

Detailed Summary:
Sponsor: Trima, Israel Pharmaceutical Products

Current Primary Outcome: Schirmer Test, Lissamine Green Test and BUT. [ Time Frame: On enrollment and one month later. ]

Original Primary Outcome: Schirmer Test and Lissamine Green Test [ Time Frame: On enrollment and one month later. ]

Current Secondary Outcome: Questionaire [ Time Frame: One, three and four weeks after treatment commencement. ]

Original Secondary Outcome: Same as current

Information By: Trima, Israel Pharmaceutical Products

Dates:
Date Received: September 23, 2007
Date Started: September 2007
Date Completion:
Last Updated: February 7, 2010
Last Verified: February 2010